Cargando…
The Significance of PSA/IGF-1 Ratio in Differentiating Benign Prostate Hyperplasia from Prostate Cancer
The importance of insulin-like growth factor 1 (IGF-1) in human serum for the early diagnosis of prostate cancer is controversial. The IGF-1/PSA ratio may improve the performance of prostate specific antigen (PSA) as a prostate cancer marker. IGF-1, along with PSA and free PSA concentration, was mea...
Autores principales: | Koliakos, G., Chatzivasiliou, D., Dimopoulos, Th., Trachana, V., Paschalidou, K., Galiamoutsas, V., Triantos, A., Chitas, G., Dimopoulos, A., Vlatsas, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851088/ https://www.ncbi.nlm.nih.gov/pubmed/11381196 http://dx.doi.org/10.1155/2000/764851 |
Ejemplares similares
-
Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia
por: Jia, Gaozhen, et al.
Publicado: (2017) -
Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity
por: Stephan, Carsten, et al.
Publicado: (2008) -
Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019) -
Benign Prostatic Hyperplasia
Publicado: (2015) -
Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA
por: Gudmundsson, Julius, et al.
Publicado: (2018)